2026 CPL & CPA Benchmark Reference

Patient Acquisition Cost by Medical Specialty: 2026 Benchmarks

Cost-per-lead and cost-per-acquired-patient vary 10× across medical specialties. The same $5,000 marketing budget produces 50 urgent care patients or 4 plastic surgery consultations. Practices comparing themselves against the wrong benchmark either panic when they’re actually doing well or relax when they’re underperforming. This is the comprehensive specialty-by-specialty benchmark reference — typical CPL ranges, target CPA, healthy LTV-to-CPA ratios, and the market factors that move the numbers up or down.

How to Read These Benchmarks

Every benchmark in this post is a range, not a single number. The range reflects the realistic spread between competently-managed campaigns in tier-2 metros at the low end and tier-1 metro competitive markets at the high end. Practices outside the range in either direction should investigate why — below the range may indicate tracking gaps inflating apparent performance, above the range may indicate genuine underperformance.

Three factors drive most of the variation within each specialty:

Market tier. Tier-1 metros (NYC, LA, San Francisco, Boston, Chicago, Miami) produce CPLs and CPAs 30–80% higher than tier-2 metros (Sacramento, Denver, Charlotte, Nashville, Salt Lake City). Tier-3 markets often run 30–50% below tier-2.

Insurance vs cash-pay. Cash-pay specialties (plastic surgery, fertility, cosmetic dental, medspa, hair transplant) have higher CPLs because patients research extensively, but typically support higher LTVs. Insurance-driven specialties (general dental, primary care, urgent care, dermatology medical) have lower CPLs but lower per-patient revenue.

Decision cycle length. Short-cycle specialties (urgent care, emergency dental) convert leads to patients quickly with low CPL-to-CPA multiplier (typically 1.5–2.5×). Long-cycle specialties (fertility, plastic surgery, complex orthopedic) have higher CPL-to-CPA multipliers (3–10×) because many leads convert months after initial inquiry.

What’s NOT included in these benchmarks:

Cost of agency retainer (separate from media spend). Cost of website maintenance and tooling. Cost of intake staff handling leads. These overhead costs are real but excluded so the benchmarks compare like-to-like across practices.

Master Benchmark Table: All Specialties at a Glance

Quick reference across all 15+ specialties. Detailed breakdowns follow.

Ranges reflect competently-managed Google Ads + Meta Ads programs across tier-1 to tier-3 US metros, 2026 benchmarks. Cross-border fertility and medical tourism programs follow different patterns covered in the Fertility section below.

Urgent Care, Primary Care, and Immediate-Need Specialties

Urgent care benchmarks. CPL $25–$80, CPA $60–$150, average per-visit revenue $200–$400. The fastest-converting specialty in medical marketing — patients searching for urgent care convert in days, often within hours. Healthy ROAS 3×–6× because per-visit revenue is modest, but lifetime value can grow as urgent care patients convert to primary care relationships.

Drivers of CPL variation: tier-1 metros ($60–$80) vs tier-3 ($25–$45). Insurance acceptance breadth (practices accepting major insurers convert better). Same-day appointment availability (signals convert dramatically better). Hours including evenings/weekends (extends qualified search window).

Primary care benchmarks. CPL $40–$120, CPA $100–$280, LTV $2K–$8K over multi-year relationship. Direct primary care (DPC) and concierge models support meaningfully higher LTVs ($8K–$25K) and corresponding higher CPA tolerance. Healthy ROAS 5×–9× over multi-year LTV.

The challenge with primary care marketing: patients with insurance often default to in-network options without active research. Marketing competes against insurance-directed selection rather than capturing search intent. Direct primary care (cash-pay model) markets more like a cash-pay specialty with higher CPL but stronger conversion.

Pediatric primary care. Similar economics to adult primary care with CPL $50–$130. Long LTVs (15–18 year patient relationships) support sustained marketing investment. Family acquisition (one pediatric patient often brings 2–3 siblings) effectively reduces functional CPA significantly below reported numbers.

Dental Specialties

General dental benchmarks. CPL $45–$140, CPA $120–$340, LTV $5K–$15K over 5–7 year relationship. Healthy ROAS 5×–10×. The dental category that competes most directly with corporate DSOs — independent practices winning on local pack dominance, provider continuity, and operational excellence (covered in the corporate dental competitive post).

Cosmetic and implant dental benchmarks. CPL $80–$280, CPA $280–$900 (single procedure CPA, not multi-visit), LTV $15K–$40K. Implant procedures often $3,500–$6,000 per implant with full-arch cases $25K–$60K supporting CPA in the $600–$1,200 range. Cosmetic veneer cases $20K–$45K with similar CPA tolerance.

Orthodontics benchmarks. CPL $60–$200, CPA $180–$580, LTV $5K–$8K per case. Family member acquisition expands functional LTV. Invisalign vs traditional braces produces different conversion patterns — Invisalign markets at higher CPL but converts adults; traditional braces lower CPL with primarily pediatric/teen demographic.

Pediatric dental benchmarks. CPL $50–$160, CPA $150–$420, LTV $4K–$12K through pediatric years plus referral to adult dental colleagues. Family acquisition is the dominant economic factor — one pediatric patient typically converts 1–2 siblings.

Endodontics, oral surgery, periodontics specialty benchmarks. CPL $80–$240 (referral-driven specialties have lower direct marketing CPL but require sustained referrer relationship investment). CPA $240–$720. Per-procedure revenue $1,500–$8,000 supports the CPA when conversion rates are healthy.

Aesthetic and Cosmetic Medicine

Plastic surgery benchmarks. CPL $100–$320, CPA $400–$1,400, average procedure revenue $5K–$30K. Healthy ROAS 4×–8×. Wide variation by procedure: tummy tuck and BBL ($600–$1,400 CPA), breast augmentation ($400–$900 CPA), facelift ($800–$1,800 CPA). Tier-1 metros (Beverly Hills, Miami, NYC) push CPL into the $250–$500+ range driven by intense competition.

Decision cycle (3–6 months typical) means CPL doesn’t immediately convert to CPA — patient may inquire in March and book surgery in August. The CPL-to-CPA multiplier for plastic surgery typically runs 4×–10×.

Hair transplant benchmarks. CPL $80–$240, CPA $320–$1,100, average procedure $8K–$25K. Cross-border medical tourism (US patients to Mexico, Turkey) produces meaningfully different economics than domestic-only programs. Spanish-language campaigns targeting Hispanic markets in TX/CA/FL can produce CPLs 30–50% below English-language equivalents (validated in case study work with Elaen Plastic Surgery in Nuevo Vallarta).

Medspa and dermatology cosmetic benchmarks. CPL $60–$180, CPA $180–$520, average first-visit revenue $400–$1,200, LTV $4K–$15K over 3 years from recurring treatments. The recurring revenue model means CPA against single-visit revenue understates the program’s true economics — LTV-based ROAS calculation typically shows 4×–8× even when single-visit ROAS appears lower.

Specific medspa procedure benchmarks:

Botox/Dysport: $40–$120 CPL, $120–$280 CPA. Volume-driven; recurring revenue model. Filler: $60–$160 CPL, $180–$420 CPA. Body contouring (CoolSculpting, EmSculpt): $80–$240 CPL, $320–$900 CPA. Laser hair removal: $40–$140 CPL, $140–$420 CPA per package. Skin tightening, microneedling: $60–$180 CPL, $200–$520 CPA.

Fertility, IVF, and Reproductive Medicine

Fertility/IVF benchmarks (domestic US). CPL $120–$380, CPA $600–$2,400, average IVF cycle $14K–$22K. Multi-cycle patients (2–3 cycles) bring LTV to $30K–$80K including cycle costs, medications, and additional services. Healthy ROAS 4×–9×.

The longest decision cycle in medical marketing — 12–18 months from initial research to first cycle is typical. CPL captured in month 1 may convert to a patient in month 14. CPA reporting in months 1–9 typically understates program performance because the funnel is still filling.

International/cross-border fertility benchmarks. Cross-border programs targeting US, UK, or European patients to clinics in Cyprus, Mexico, or Spain produce substantially different economics. CPL $150–$450, CPA $800–$3,500, but average cycle revenue $8K–$15K (lower than US domestic) with higher conversion-to-cycle rates (cost-conscious patients are more committed).

The ROAS math typically still works at 4×–7× because of multi-country audience scale and lower competitive intensity. EuroCARE IVF operations across UK and Scandinavian markets validate this pattern — 4.6× ROAS sustained across UK/Scandinavia/Germany/Ireland with combined ~$5,000/mo budget producing competitive position.

Egg donor IVF, surrogacy, gender selection. Higher per-cycle revenue ($25K–$80K+) supports CPL up to $500 and CPA up to $4,000. Lower volume but higher per-acquisition value. Marketing optimization centers on high-intent search capture rather than awareness building.

Egg freezing. CPL $90–$240, CPA $400–$1,200. Different patient profile than full IVF (younger, often pre-relationship). Marketing typically more retargeting-driven and content-heavy than IVF.

Surgical Specialties (Bariatric, Orthopedic, Spine)

Bariatric surgery benchmarks. CPL $80–$260, CPA $400–$1,800, average procedure $15K–$40K. Insurance-covered cases (Medicare, BCBS, etc.) have lower per-patient revenue but higher conversion rates; cash-pay programs (Mexico, lower-cost domestic) have higher per-patient revenue but require more education and longer decision cycles.

Three program models with different economics:

Insurance-driven domestic programs: lower CPL ($60–$160), CPA $200–$800, conversion friction primarily insurance pre-authorization. Cash-pay domestic programs: CPL $100–$240, CPA $500–$1,500, longer education/decision cycle. Cross-border programs (Tijuana, Cancun): CPL $80–$200, CPA $400–$1,200, dramatically lower per-procedure revenue ($6K–$12K) but high volume potential.

Orthopedic and spine benchmarks. CPL $80–$280, CPA $280–$1,200 depending on procedure complexity. Total joint replacement (knee, hip): $40K–$70K per procedure, supporting CPA in the $500–$1,500 range. Spine surgery cases: $25K–$80K per procedure. Sports medicine and outpatient orthopedic: lower per-procedure revenue ($3K–$12K) with corresponding lower CPA tolerance.

Insurance influence is heavy in orthopedic. Patients with insurance often have limited provider choice. Marketing competes most effectively for elective and cash-pay procedures (cosmetic orthopedic, sports performance, elective orthobiologic injections, regenerative medicine).

Vein and vascular benchmarks. CPL $80–$240, CPA $240–$720. Cosmetic vein procedures (sclerotherapy, vein removal) cash-pay with quick decision cycles. Medical vascular (DVT screening, varicose vein treatment) often insurance-covered.

Other High-Volume Specialties

OB-GYN benchmarks. CPL $50–$160, CPA $140–$420, LTV $5K–$18K including pregnancy/delivery + ongoing women’s health. Practices accepting maternity coverage produce different economics than gynecology-only practices. Annual exam acquisition is a low-CPA entry point that converts to higher-value services.

Mental health benchmarks. CPL $60–$180, CPA $180–$520, LTV $8K–$25K over 2–3 year treatment relationships. Telehealth-only practices have meaningfully different economics than in-person practices — broader geographic reach but more competition. Subscription-based mental health platforms (BetterHelp, Cerebral) compete heavily on Google Ads, increasing CPLs for traditional practices.

LASIK/eye surgery benchmarks. CPL $80–$240, CPA $280–$900, average bilateral procedure $4K–$8K. Healthy ROAS 4×–7×. Low repeat business limits LTV expansion — CPA economics need to work primarily on the single procedure. Cataract surgery often medicare-covered with different economics; refractive surgery cash-pay.

Men’s health (TRT, ED, hair, fertility) benchmarks. CPL $60–$180, CPA $200–$680, recurring monthly revenue $200–$600. Telehealth disruption (Hims, Roman, Bluechew) has dramatically increased competitive intensity and CPLs for traditional men’s health practices. Differentiated positioning (specialty-physician-led, complex cases, in-person care) supports higher CPL tolerance.

Concierge/direct primary care benchmarks. CPL $90–$280, CPA $260–$840, LTV $8K–$25K over 3–5 year membership. Cash-pay model produces clearer ROAS calculation than insurance-based primary care. Family memberships expand effective LTV substantially.

Addiction treatment and behavioral health residential benchmarks. CPL $200–$600, CPA $1,500–$6,000+ (highest CPA in medical marketing), per-admission revenue $20K–$80K. Restricted advertising category with policy compliance challenges. Marketing typically requires legal review of platforms, ad copy, and targeting due to consumer protection regulations specific to this category.

How to Use These Benchmarks Strategically

The benchmarks are reference points, not targets. Practical applications:

1. Diagnostic comparison. Pull current CPA and ROAS from your practice. Find your specialty in the benchmark table. If you’re 30%+ below the lower bound (better than expected), investigate whether tracking is incomplete or whether you’re genuinely outperforming. If you’re 30%+ above the upper bound (worse than expected), use the seven-failure-point diagnostic to identify root causes.

2. Budget allocation across services. Multi-service practices often allocate budget proportionally across services. Better practice: weight allocation toward services where your CPA-to-LTV math is strongest. A practice with $300 dental implant CPA against $25K LTV has dramatically better unit economics than a $180 general dental CPA against $7,500 LTV — even though dental implants “cost more.” Allocate disproportionately to the strongest LTV ratio.

3. Setting agency performance expectations. Provide your specialty benchmarks to your agency at engagement start. Set 90-day target as the upper bound of the CPA range; 6-month target as the middle of the range; 12-month target as the lower bound. Concrete numbers in writing prevent vague “continued optimization” reporting.

4. Evaluating new specialty additions. Adding a new service line (general dental practice adding implants, plastic surgeon adding medspa) requires understanding the new service’s specific economics. Benchmark against the relevant specialty before launch to avoid surprise economics post-launch.

5. Evaluating market opportunities. Cross-border, multi-country, and Spanish-language market expansion changes the economics of specialties materially. Use the benchmark variations (international fertility, Spanish-language hair transplant) to evaluate market opportunities before committing budget.

6. Competitive analysis. Public competitor data (review counts, ad position, content depth) lets you estimate competitor marketing scale. A competitor with 600 reviews vs your 80, 3 ad positions vs your 1, 200 content pages vs your 30 is operating at a meaningfully different scale — their unit economics likely differ from yours and the benchmarks above.

Common Mistakes in Using Benchmarks

Recurring patterns of misuse that lead to bad decisions:

Comparing your specialty against the wrong benchmark. A general dental practice using cosmetic dental benchmarks. A medspa using plastic surgery benchmarks. The economics differ enough that wrong-specialty comparison produces false signals.

Comparing tier-1 metro to tier-3 metro benchmarks (or vice versa). Same specialty, different metro tier produces 30–80% benchmark variation. Calibrate the range to your specific market tier.

Using single-visit revenue as the LTV input. A medspa CPA looks bad against $400 single-visit revenue but excellent against $12,000 three-year LTV. Always calculate LTV-based ratios, not single-transaction ratios.

Judging campaigns at month 3 against month-12 benchmarks. The benchmarks reflect mature program performance. New programs in months 1–3 typically run 30–70% above mature CPA. Cutting budget at month 3 because CPA is above the benchmark is the most common premature-evaluation mistake.

Ignoring intake response time impact. Same campaign produces dramatically different CPA depending on intake response speed. Practices with 5-minute callback CPAs might run at the lower bound of the benchmark; practices with 4-hour callback at the upper bound. The marketing isn’t different — the operations are.

Treating benchmarks as targets to celebrate hitting. The benchmarks reflect typical performance. Best-in-class practices consistently outperform the lower bound. Hitting the middle of the range is acceptable; not optimal. The optimization goal is moving toward and below the lower bound over time.

Want a CPA gap analysis specific to your practice?

Tandem audits current marketing performance against specialty-specific benchmarks for your specific tier and market — with explicit gap calculation and the moves that close it. Free audit, written report.

Frequently Asked Questions

What is a good cost per lead for medical practices?

It varies 10× across specialties. Urgent care and primary care: $25–$120. General dental and dermatology: $45–$140. Orthodontics, cosmetic dental, medspa: $60–$200. Plastic surgery, fertility, complex orthopedic: $100–$380. The right CPL depends on the patient lifetime value the lead can produce — high-LTV specialties tolerate higher CPLs. Compare LTV-to-CPA ratios, not raw CPL numbers.

What is a good cost per acquired patient in medical marketing?

Healthy LTV-to-CPA ratio is 10:1 or higher; 5:1 is concerning; below 3:1 is failing. Translated to absolute numbers by specialty: urgent care $60–$150, general dental $120–$340, plastic surgery $400–$1,400, fertility $600–$2,400, complex orthopedic $280–$1,200. The CPA target is downstream of the specialty’s LTV — a $400 CPA in fertility (LTV $30K+) is excellent; the same $400 CPA in general dental (LTV $7,500) is concerning.

Why is CPA so different across medical specialties?

Three factors drive most variation: market tier (tier-1 metros run 30–80% higher than tier-3), insurance vs cash-pay model, and decision cycle length. Cash-pay specialties have higher CPLs because patients research extensively but support higher LTVs. Long-cycle specialties (fertility, plastic surgery) have higher CPL-to-CPA multipliers because leads convert months after inquiry.

What is a good ROAS for medical marketing?

Healthy sustained 6-month ROAS runs 3×–8× for cash-pay specialties and 5×–10× for insurance-driven specialties (where LTVs are calculated against multi-year revenue). Below 3× sustained signals real problems. Above 8× sustained over multiple quarters is exceptional. The right ROAS target depends on specialty and patient lifetime value calculation methodology.

How does cross-border medical tourism change CPA economics?

Cross-border programs (US patients to Mexico/Turkey, UK patients to Cyprus, etc.) typically have CPLs 20–40% higher than domestic-only programs but conversion rates higher (cost-conscious patients are more committed) and per-procedure revenue lower. Net economics typically still produce 4×–7× ROAS because of multi-country audience scale and lower competitive intensity. Multi-language execution and currency-aware landing pages are required execution components.

Why is fertility CPA so high compared to other specialties?

Three structural reasons: longest decision cycle in medical marketing (12–18 months from research to first cycle), highest competitive intensity in tier-1 metros (CPLs $300–$500+ in NYC, LA, San Francisco), and most extensive patient research process. The high CPA is offset by very high LTV ($30K–$80K including cycles, medications, additional services) producing healthy 4×–9× ROAS at scale. Funnel timing means CPA reporting in months 1–9 typically understates true performance.

What’s the lowest CPA medical specialty?

Urgent care, with CPA $60–$150 in most markets. Short decision cycle, broad patient demographic, immediate-need search intent, and modest per-visit revenue produces the lowest absolute CPA across medical marketing. The low CPA is appropriate — per-visit revenue ($200–$400) supports modest CPA tolerance, with longer-term LTV growing as urgent care patients convert to primary care relationships.

How does intake response time affect CPA?

Significantly. Same campaign produces dramatically different CPA depending on intake response speed. A practice with 5-minute callback typically runs at the lower bound of specialty benchmark; practices with 4-hour callback at the upper bound. The marketing produces equivalent leads; intake conversion is what differs. Practices dissatisfied with their CPA should audit intake response time before assuming the marketing is the issue.

Are these benchmarks valid for telehealth-only medical practices?

Partially. Telehealth-only practices typically have broader geographic targeting (multi-state or national rather than local) and face different competitive dynamics — often competing against subscription-based platforms (BetterHelp, Hims, Cerebral). CPLs typically run 20–50% higher than equivalent in-person specialty due to platform competition. CPA discipline still applies; LTV calculation methodology differs because subscription-based revenue is more predictable than in-person episodic care.

Built for benchmark-driven evaluation

Stop guessing if your CPA is competitive.

A free audit calculates your specialty-specific gap to benchmark, identifies the operational and campaign factors driving it, and provides the specific moves to close the gap. Flat-fee quote within 48 hours.

Book your free audit →

Read: How to track medical marketing ROI